Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
Stryker Corporation logo

NASDAQ · SYK

Stryker Corporation

Healthcare · Medical - Devices

$339.65

Up+$29.10 (+9.37%)

Updated Nov 5, 2026, 6:15 AM

SID Score

5.9/10

Composite research score

Smart Money

35/100

Bearish

Market cap
134.97B
P/E ratio
45.86
Dividend yield
0.99%
52-week range
$267.00 – $389.33
Volume
6.49M
Avg. volume
1.61M

Price performance · SYK

SYK price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

SYK closed at $339.65 after 21 trading sessions, up 23.33% for the selected period.

Last close
$339.65
Period change
+23.33%
Period low
$275.40
Period high
$339.65
Daily close
View OHLC price history
SYK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$327.94$342.65$322.00$339.656.49M
Nov 3, 2026$307.12$312.74$306.41$310.552.59M
Nov 2, 2026$294.31$307.895$293.00$306.813.74M
Oct 30, 2026$287.97$299.17$282.18$291.866.44M
Oct 29, 2026$306.99$312.795$305.87$311.753.08M
Oct 28, 2026$297.52$305.29$297.00$304.002.33M
Oct 27, 2026$304.06$305.62$298.86$301.422.27M
Oct 26, 2026$305.43$307.47$301.78$306.131.89M
Oct 23, 2026$305.01$309.57$305.00$307.151.98M
Oct 22, 2026$299.80$309.68$299.36$307.082.8M
Oct 21, 2026$297.57$303.66$293.10$297.602.41M
Oct 20, 2026$302.29$305.03$298.932$304.403.17M
Oct 19, 2026$290.42$301.15$290.01$297.943.06M
Oct 16, 2026$295.89$299.6699$293.75$294.663.38M
Oct 15, 2026$287.00$293.99$286.55$293.233.12M
Oct 14, 2026$285.66$285.66$278.575$281.622.23M
Oct 13, 2026$284.23$287.45$278.62$282.552.07M
Oct 12, 2026$277.30$283.65$274.50$282.601.81M
Oct 9, 2026$277.01$281.58$276.53$277.331.48M
Oct 8, 2026$275.72$277.97$271.67$276.972.98M
Oct 7, 2026$280.16$281.96$274.45$275.401.92M

Latest SYK news

The latest Smart Investors Daily articles mentioning SYK.

Stock researchCompany · Overview

SYK research

Overview

Company profile and research snapshot.

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$419.33
Implied upside
—
Analysts
20
SYK recent ratings
DateFirmRatingTarget
Nov 2, 2026StifelBuy—
Nov 2, 2026Truist SecuritiesHold—
Oct 30, 2026CitigroupBuy—
Oct 30, 2026TD CowenHold—
Oct 30, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 31, 2026

Stryker Stock After Guidance Cut Has The Bull Case Changed?

Stryker reported third quarter 2026 results with sales of US$6.52b and net income of US$753m, alongside a US$293m goodwill impairment and a cut to full year guidance. The mix of softer hip and knee procedure volumes, higher costs that pressured margins, and a sizeable goodwill write down highlighted specific operational and demand pressures inside Stryker’s portfolio. The focus now turns to how Stryker’s investment narrative holds up in light of weaker joint replacement trends and reduced...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By